The role of 5HT1D-receptor agonists and magnesium in the treatment of migraine headache

被引：0
|
作者：
Alexander Mauskop
Jerome Goldstein
机构：
来源：
Current Pain and Headache Reports | 1997年 / 1卷 / 3期
关键词：
Migraine; Sumatriptan; Migraine Attack; Migraine Headache; Zolmitriptan;
D O I：
10.1007/BF02938172
中图分类号：
学科分类号：
摘要：
This article reviews two interesting topics in migraine treatment research. First, the effectiveness of sumatriptan is compared with that of the newer 5HT1D-agonists. Second, recent discoveries regarding the effect of magnesium on brain chemistry have yielcled evidence that this element may have a role in migraine. We offer our findings and opinion on this subject.
引用
收藏
页码：246 / 250
页数：4
相关论文
共 50 条
  • [31] AGONIST ACTIVITY OF SUMATRIPTAN AND METERGOLINE AT THE HUMAN 5-HT1D-BETA RECEPTOR - FURTHER EVIDENCE FOR A ROLE OF THE 5-HT1D RECEPTOR IN THE ACTION OF SUMATRIPTAN
    MILLER, KJ
    KING, A
    DEMCHYSHYN, L
    NIZNIK, H
    TEITLER, M
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (01): : 99 - 102
  • [32] Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
    S Kori
    J Zhang
    D Kellerman
    T Armer
    P Goadsby
    The Journal of Headache and Pain, 2013, 14
  • [33] The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
    Raffaelli, Bianca
    Israel, Heike
    Neeb, Lars
    Reuter, Uwe
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1409 - 1415
  • [34] No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries:: similarity with human coronary artery
    Bouchelet, I
    Case, B
    Olivier, A
    Hamel, E
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) : 501 - 508
  • [35] Differentiating the efficacy of 5-HT1B/1D agonists
    Sheftell, FD
    Fox, AW
    Weeks, RE
    Tepper, SJ
    HEADACHE, 2001, 41 (03): : 257 - 263
  • [36] Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat
    Storer, RJ
    Goadsby, PJ
    BRAIN, 1997, 120 : 2171 - 2177
  • [37] Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat
    Hoskin, KL
    Goadsby, PJ
    EXPERIMENTAL NEUROLOGY, 1998, 150 (01) : 45 - 51
  • [38] 5-hydroxytryptamine in migraine: The puzzling role of ionotropic 5-HT3 receptor in the context of established therapeutic effect of metabotropic 5-HT1 subtypes
    Giniatullin, Rashid
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (03) : 400 - 415
  • [39] Brainstem changes in 5-HT1A receptor availability during migraine attack
    Demarquay, G.
    Lothe, A.
    Royet, J. P.
    Costes, N.
    Mick, G.
    Mauguiere, F.
    Ryvlin, P.
    CEPHALALGIA, 2011, 31 (01) : 84 - 94
  • [40] Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input
    Goadsby, PJ
    Classey, JD
    NEUROSCIENCE, 2003, 122 (02) : 491 - 498
12345